| Zacks Company Profile for Lonza Group Ag (LZAGY : OTC) |
|
|
| |
| • Company Description |
| Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Number of Employees: 16,540 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $55.60 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 101,649 shares |
| Shares Outstanding: (millions) |
| Market Capitalization: $ (millions) |
| Beta: 0.90 |
| 52 Week High: $85.53 |
| 52 Week Low: $51.78 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
-16.75% |
-9.15% |
| 12 Week |
-15.44% |
-10.97% |
| Year To Date |
-33.41% |
-22.38% |
|
|
|
|
| |
|
|
| |
| • General Corporate Information |
Officers
Pierre-Alain Ruffieux - Chief Executive Officer
Stefan Stoffel - Chief Operating Officer
Rodolfo J. Savitzky - Chief Financial Officer
Caroline Barth - Chief Human Resource Officer
- - -
|
|
Peer Information
Lonza Group Ag (BJCT)
Lonza Group Ag (CADMQ)
Lonza Group Ag (APNO)
Lonza Group Ag (UPDC)
Lonza Group Ag (IMTIQ)
Lonza Group Ag (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 54338V101
SIC: 2100
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
|
|
Share - Related Items
Shares Outstanding:
Most Recent Split Date: (:1)
Beta: 0.90
Market Capitalization: $ (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.16% |
| Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $0.09 |
| Current Fiscal Year EPS Consensus Estimate: $1.71 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: 05/09/2022 - $0.13 |
| Next EPS Report Date: - |
|
|
|
| |
